Taurine chloramine inhibits NO and TNF-αproduction in zymosan plus interferon-γactivated RAW 264.7 cells

Journal of Drugs in Dermatology

Volumn 10, Issue 6, 2011, Pages 659-665

  Kim, Bo Sook ^a   Cho, In Soo ^b   Park, Seung Yong ^c   Schuller Levis, Georgia ^d   Levis, William ^e   Park, Eunkyue ^d  

^a Seoul Grand Park Zoo   (South Korea)

^b Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^c Konkuk University   (South Korea)

^d NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRITE; TAURINE CHLORAMINE; TAURINE DERIVATIVE; TAURINE TRANSPORTER; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHYSIOLOGY; SKIN DISEASE; TISSUE INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INTERFERON-GAMMA; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TAURINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 80053067467     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Reid DM, Gow NA, Brown GD. Pattern recognition: Recent insights from dectin-1. Curr Opin Immunol. 2009;21:30-37.
2. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009;21:317-337.
3. Sato M, Sano H, Iwak D, et al. Direct bining of toll-like-receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-αsecretion are down-regulatated by lung collectin surfactant protein A. J Immunol. 2003;171:417-425. (Pubitemid 36745315)
4. Cuzzocrea S, Flippelli A, Zingarelli B, et al. Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat. Shock. 1997;7:351-357. (Pubitemid 127654292)
5. Hashomoto T, Ohno N, Adachi Y, et al. Nitric oxide synthesis in murine peritoneal macrophages by fungal beta-glucans. Biol Pharm Bull. 1997;20:1006-1009. (Pubitemid 27432877)
6. Boughton-Smith NK, Ghelan A. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat. Inflamm Res. 1995;44(suppl 2):149S-150S.
7. Kankkunen P, Teirila L, Rintahaka J, et al. (1,3)-β-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J Immunol. 2010;184:6335-6342.
8. Sturman JA. Taurine in development. Physiol Rev. 1993;73:119-146.
9. Fudaka K, Hirai Y, Yoshida H, et al. Free amino acid content of lymphocytes and granulocytes compared. Clin Chem. 1982;28:1758-1761. (Pubitemid 12039726)
10. Warskulat U, Reinen A, Grether-Beck S, et al. The osmolyte strategy of normal human keratinocytes in maintaining cell homeostasis. J Invest Dermatol. 2004;123(30):516-521. (Pubitemid 39095622)
11. Wang QJ, Hollinger MA, Giri SN. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Ther. 199;262:127-132.
12. Gould RE, Shaked AA, Solan DF. Taurine protects hamster bronchioles from acute NO2 induced alterations. Am J Pathol.1985;125:585-600.
13. Schuller-Levis G, Gordon R, Park E, et al. Taurine protects rat bronchioles from acute ozone-induced lung inflammation and hyperplasia. Exp Lung Res. 1995;21:877-888.
14. Schuller-Levis G, Gordon R, Wang C et al. Protection of bleomycin-induced fibrosis and inflammation by taurine. Int Immunopharm. 2009;9:971-977.
15. Weiss SJ, Klein R, Slivka A, et al. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982;70:598-607. (Pubitemid 12054584)
16. Grisham MB, Jefferson MM, Melton DF, et al. Chlorination of endogenous amines by isolated neutrophils, J Biol Chem. 1984;259:10404-10413.
17. Catin AM, Taurine modulation of hypochlorous acid-inducing lung epithelial cell injury in vitro, role of anion transport. J Clin Invest. 1994;93:606-614.
18. Park E, Quinn MR, Wright CE et al. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol. 1993;54(2):119-124. (Pubitemid 23276400)
19. Park E, Schuller-Levis G, Quinn MR, Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol. 1995;154(9):4778-4784.
20. Kim C, Park E, Quinn MR, et al. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in conditioned media is inhibited by taurine chloramine. Immunopharmacol. 1996;34:89-95. (Pubitemid 26290386)
21. Park E, Alberti J, Quinn MR, et al. Taurine chloramine inhibits production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv Exp Med Biol. 1998;442:117-182.
22. Quinn MR, Park E, Schuller-Levis G, Taurine chloramine inhibits prostaglandin E2 production in activated RAW 264.7 cells. Immunol Lett. 1996;50:185-188.
23. Marcinkiewicz J, Grabowska A, Berata J, et al. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. Leukoc Biol. 1995;58:667-674. (Pubitemid 26033855)
24. Park E, Jia J, Quinn MR, et al. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol. 2002;102:179-184. (Pubitemid 34171517)
25. Janeke G, Siefken W, Carstensen S, et al. Role of taurine accumulation in keratinocyte hydration. J Invest Dermatol. 2003;121(2):354-361. (Pubitemid 36969910)
26. Elias PM. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol. 2010;22(3):245-254.
27. Li C, Lasse S, Lee P, et al. Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8. Proc Natl Acad Sci U S A. 2010;107(51):22249-22254. Epub December 6, 2010.
28. Jakasa I, Koster ES, Calkoen F, et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol. 2011;131(2):540-542. Epub October 21, 2010.
29. Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg. 2010;29(1):3-9.
30. Fuentes-Duculan J, Suarez-Farifias M, Zaba LC, et al. A subpopulation of CD163-positive macrophages is classically activated in proriasis. J Invest Dermatol. 2010;130(10):2412-2422.
31. Honggin T, Xinyu L, Heng G et al. Triptolide inhibits IFN-γ signaling via the Jak/STAT pathway in HaCaT Keratinocytes. Phytother Res. Epub March 42, 2011. doi:10,1002/ptr.3471.
32. Farkas A. Kemeny L. Interferon-alpha in the generation of monocyte-derived dendritic cells: Recent advances and implication for dermatology. Br J Dermatol. Epub March 17, 2011. doi: 10,1111/j.1365-2133.2011. 10301.x.
33. Underhill DM, Rossnagle E, Lowell CA, et al. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood. 2005;106:2543-2550. (Pubitemid 41510832)
34. Gross A. Gewies K. Finger M, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 2006;442:651-656.
35. Barua M, Liu Y, Quinn MR. Taurine chloramines inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: Decreased NF-κB activation and IκB kinase activity. J Immunol. 2002;167:2275-2281. (Pubitemid 32747540)
36. Joo K, Lee Y, Choi D, et al. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: Taurine chloramines potentiates inhibitory effect of 5-aminosalicylic acid on IL-1β-mediated NF-κB activation. Eur J Phamacol. 2009;618:91-97.
37. Chorazy-Massalska M, Kontny E, Kornatka A, et al. The effect of taurine chloramines on pro-inflammatory cytokine production by peripheral blood mononuclear cells isolated form rheumatoid arthritis and osteoarthritis patients. Clin Exp Rheumatol. 2004;22:692-698. (Pubitemid 40045530)
38. Sieling PA, Hill PJ, Dobos KM, et al. Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation. J Immunol. 2008;180:5833-5842.
39. Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterum tuberculosis infection in mice. J Immunol. 2002;169:3155-3162. (Pubitemid 35013161)
40. Park E, Levis WR, Quinn MR, et al. Regulation of nitric oxide induced by mycobacterial lipoarabinomannan in murine macrophages: Effects of interferon-beta and taurine chloramine. Int J Lepr Other Mycobact Dis. 2000;68(4):444-451. (Pubitemid 32322344)
41. Levis W, Schuller-Levis GB, Park E. Deficient tumor necrosis factor-α production in lipoarabinomannan activated macrophages from toll-like receptor-4 deficient mice: Implication for mycobacterial susceptibility. Int J Leprosy. 2003;71:1-9. (Pubitemid 36927690)
42. Yim SM, Kim JY, Ko JH, et al. Molecular analysis of Malassezia microflora on the skin of the patients with atopic dermatitis. Ann Dematol. 2010;22(1):41-47.
43. De Koning HD, Rodijk-Olthuis D, Van Vlijmen-Willems IM, et al. A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: Upregulation of dectin-1 in psoriasis. J Invest Dermatol. 2010;130(11):2611-2620.
44. Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev. 2010;21(6):435-441.
45. Paulino LC, Tseng CH, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 2008;8(3):460-471. (Pubitemid 351579659)
46. Kanda N, Tani K, Enomoto U, et al. The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. Clin Exp Allergy. 2002;32(8):1243-1250. (Pubitemid 35007431)
47. Fujita H, Nograles KE, Kikuchi T, et al. Human Langerhans cells induce IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A. 2009;106(51):21795-21800.
48. Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol. 2009;123(6):1244-1252.
49. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. I Immunol 2008;181(10):7420-7427.
50. Koga C, Kabashima K, Shiraishi N, et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128(11):2625-2630.